Management of Silicone Breast Implant Rupture in Relation to Sarcoidosis
The definitive treatment for silicone breast implant rupture, regardless of sarcoidosis status, is surgical removal of the ruptured implant and surrounding capsule (explantation with capsulectomy), with or without replacement. 1, 2
Diagnosis of Implant Rupture
Initial Evaluation
- MRI without contrast is the gold standard recommended by the FDA for evaluating silicone implant rupture 1
- Alternative imaging options when MRI is contraindicated:
Imaging Findings
Intracapsular rupture (most common):
Extracapsular rupture:
Treatment Algorithm
Confirm diagnosis with appropriate imaging (preferably MRI without contrast) 1
For symptomatic patients with confirmed rupture:
For asymptomatic patients with confirmed rupture:
Special considerations with sarcoidosis:
Important Clinical Considerations
- Rupture rates increase significantly after 6-8 years of implantation 2
- Most silicone implant ruptures (especially intracapsular) are clinically undetectable 2, 4
- The most common cause of implant rupture is iatrogenic damage during placement 5
- Migration patterns differ between saline and silicone implants - saline is resorbed while silicone can persist and migrate 3
Pitfalls to Avoid
- Relying solely on clinical examination, which is unreliable for detecting implant rupture 1, 3
- Misinterpreting MRI findings - be aware of potential false positives such as the "rat-tail" sign 6
- Delaying treatment of extracapsular rupture, which increases risk of silicone migration to distant tissues 3, 4
- Assuming immediate health risks - current consensus indicates no significant health risks associated with implant rupture, allowing time for proper surgical planning 2, 4
Follow-up for Non-Surgical Management
- If observation is chosen, regular clinical and imaging follow-up is recommended 4
- Monitor for progression of silicone seepage or conversion from intracapsular to extracapsular rupture 4
- Be alert for new symptoms including breast changes, which occur more frequently in women with untreated ruptures (odds ratio 2.1) 4